BRWA
WST icon

B. Riley Wealth Advisors’s West Pharmaceutical WST Stock Holding History

B. Riley Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,159
Closed -$483K – 1381
2025
Q1 		$483K Buy
2,159
+489
+29% +$135K 0.01% 775
2024
Q4 		$547K Buy
1,670
+187
+13% +$58.9K 0.02% 664
2024
Q3 		$444K Sell
1,483
-73
-5% -$22.4K 0.01% 783
2024
Q2 		$513K Buy
1,556
+995
+177% +$352K 0.01% 805
2024
Q1 		$211K Buy
+561
New +$208K 0.01% 1246
2023
Q4 		– Sell
-561
Closed -$211K – 1515
2023
Q3 		$211K Buy
+561
New +$217K 0.01% 1246
2022
Q4 		– Sell
-924
Closed -$228K – 1598
2022
Q3 		$228K Sell
924
-107
-10% -$32.6K 0.01% 1168
2022
Q2 		$312K Sell
1,031
-1,238
-55% -$403K 0.01% 861
2022
Q1 		$933K Buy
2,269
+241
+12% +$94.3K 0.03% 520
2021
Q4 		$951K Buy
2,028
+104
+5% +$44.8K 0.03% 545
2021
Q3 		$817K Sell
1,924
-85
-4% -$35.8K 0.03% 587
2021
Q2 		$722K Sell
2,009
-689
-26% -$228K 0.02% 626
2021
Q1 		$761K Buy
2,698
+762
+39% +$218K 0.03% 566
2020
Q4 		$549K Sell
1,936
-120
-6% -$33.7K 0.03% 509
2020
Q3 		$553K Buy
+2,056
New +$544K 0.03% 497
2019
Q4 		– Sell
-4,193
Closed -$595K – 910
2019
Q3 		$595K Buy
4,193
+724
+21% +$99.7K 0.06% 346
2019
Q2 		$435K Buy
3,469
+1,050
+43% +$124K 0.05% 427
2019
Q1 		$267K Buy
+2,419
New +$252K 0.03% 553
2015
Q1 		– Sell
-177
Closed -$9K – 1996
2014
Q4 		$9K Buy
+177
New +$8.85K ﹤0.01% 2940
2014
Q3 		– Sell
-9
Closed -$386 – 1903
2014
Q2 		$386 Buy
+9
New +$385 ﹤0.01% 2345

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

B. Riley Wealth Advisors's WST Position: Q2 2025 in Review

B. Riley Wealth Advisors sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 2,159 shares — an estimated $483K sold.

B. Riley Wealth Advisors first reported a position in WST in Q2 2014 and held it in 20 quarters. The position peaked at $951K in Q4 2021. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • B. Riley Wealth Advisors reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 2,159 West Pharmaceutical shares in Q2 2025, an estimated $483K.
  • B. Riley Wealth Advisors first reported a position in West Pharmaceutical in Q2 2014 and held it in 20 quarters.
  • B. Riley Wealth Advisors's West Pharmaceutical position peaked at $951K in Q4 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2025, filed 19 Aug 2025.